Mesoblast
MESO
#4320
Rank
ยฃ1.83 B
Marketcap
ยฃ14.27
Share price
1.55%
Change (1 day)
67.83%
Change (1 year)

Mesoblast (MESO) - Cash on Hand

Cash on Hand as of June 2025 : ยฃ0.12 Billion

According to Mesoblast 's latest financial reports the company has ยฃ0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Mesoblast - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30ยฃ49.46 M-11.34%
2023-06-30ยฃ55.78 M13.01%
2022-06-30ยฃ49.36 M-49.96%
2021-06-30ยฃ98.65 M-5.19%
2020-06-30ยฃ0.10 B164.16%
2019-06-30ยฃ39.39 M39.79%
2018-06-30ยฃ28.17 M374.65%
2017-06-30ยฃ5.93 M-63.8%
2016-06-30ยฃ16.4 M21.78%
2015-06-30ยฃ13.46 M502.09%
2014-06-30ยฃ2.23 M-56.81%
2013-06-30ยฃ5.17 M485.42%
2012-06-30ยฃ0.88 M-99.46%
2011-06-30ยฃ0.16 B676.17%
2010-06-30ยฃ21.13 M110.71%
2009-06-30ยฃ10.02 M41.64%
2008-06-30ยฃ7.08 M17.6%
2007-06-30ยฃ6.02 M40.15%
2006-06-30ยฃ4.29 M-49.65%
2005-06-30ยฃ8.53 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
ยฃ1.66 M-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
ยฃ0.09 M-99.92% Bahamas